comparemela.com

Issei Komuro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fujitsu, University of Tokyo Hospital to research AI in fight against heart disease

Fujitsu Ltd has started joint clinical research with the University of Tokyo Hospital to verify the effectiveness of artificial intelligence technology to estimate abnormal heart movements based on electrocardiogram data. The research commenced at the University of Tokyo Hospital on Oct 25. Since December 2019, Fujitsu has been making progress with…

Activation of Sympathetic Signaling in Macrophages Blocks Systemic Inflammation and Protects against Renal Ischemia-Reperfusion Injury

Activation of Sympathetic Signaling in Macrophages Blocks Systemic Inflammation and Protects against Renal Ischemia-Reperfusion Injury
asnjournals.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asnjournals.org Daily Mail and Mail on Sunday newspapers.

How is Cardio-Oncology Advancing in Japan? - American College of Cardiology

How is Cardio-Oncology Advancing in Japan? Dec 17, 2020 A Cancer and cardiovascular disease are the leading causes of death in Japan, a country with a rapidly increasing elderly population. While Japan has made progress in reducing cancer mortality, there has been an increase in the number of cancer survivors. Consequently, Japan is seeing an increase in cardiovascular events related to cancer treatment. To address the growing field of cardio-oncology in Japan, Issei Komuro, MD, PhD, president of the Japanese Onco-Cardiology Society, published two perspectives Dec. 15 in JACC: CardioOncology. Chikashi Ishiola, MD, PhD, president of the Japanese Society of Medical Oncology, discuss the growing demand for treatment of cancer patients with cardiovascular comorbidities or complications. They explain that cardiologists need information and knowledge of current cancer therapies; and in turn, oncologists require the same information and knowledge of cardiovascular dise

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.